摘要
药品发展风险的存在使得药品不良反应难以避免,不可预期。从损害填补的原则出发,中国现阶段应当建立药品不良反应损害基金制度,平衡各主体之间的责任分担。从危险预防的角度和损失分散的角度来分析,药品的生产者、进口者、销售者、政府均应分担药品不良反应的损害具有正当性,而不应由消费者承担。
Because of the drug development risk, adverse drug reaction is inevitable and cannot to be expected. From the perspective of damage compensation, China should establish the fund system of adverse drug reaction for balancing the responsibility sharing among subjects. From the perspective of risk prevention and loss of dispersion, the manufacturer, importer, distributor, government should share the damage of adverse drug reaction, but not by consumers.
出处
《医学与哲学（A）》
北大核心
2012年第9期48-50,57,共4页
Medicine & Philosophy:Humanistic & Social Medicine Edition
基金
东莞市社会科学界联合会课题"药品不良反应的法律控制和救济研究"
项目编号:2011JY28
广东医学院课题"药品不良反应的法律控制和救济实证研究"
项目编号:Q2010031
关键词
药品不良反应
药品发展风险
药品安全
adverse drug reaction, drug development risk, drug safety
